Metadata about: Secukinumab

About: Secukinumab

an Entity references as follows:

Secukinumab, sold under the brand name Cosentyx, is a human IgG1κ monoclonal antibody used for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. It binds to the protein interleukin (IL)-17A and is marketed by Novartis.

Subject of Sentences In Document

Object of Sentences In Document

Explicit Coreferences

Implicit Coreferences

Graph IRI	Count
http://dbpedia.org/resource/Secukinumab	158
http://ns.inria.fr/covid19/graph/dbpedia-named-entities	11
http://dbpedia.org/resource/Category:Monoclonal_antibodies	3
http://dbpedia.org/resource/Category:Immunosuppressants	3
http://dbpedia.org/resource/Monoclonal_antibody	2
http://dbpedia.org/resource/Endocytosis	2
http://dbpedia.org/class/yago/Drug103247620	2
http://dbpedia.org/resource/Inflammatory_bowel_disease	2
http://dbpedia.org/resource/Cytokine	2
http://dbpedia.org/class/yago/Agent114778436	2
http://dbpedia.org/resource/Template:Fdacite	2
http://dbpedia.org/resource/Interleukin_17	2

Faceted Search & Find service v1.13.91

This work is licensed under a Creative Commons Attribution-Share Alike 3.0 Unported License.
OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Copyright © 2009-2025 OpenLink Software